Search research articles
Contact Us
Filters
Showing results (511-520 of 1,115) with videos related to
Page
of 112
Sort By:
Cancer
|
April 1, 1987
Role of maintenance chemotherapy in acute promyelocytic leukemia
H M Kantarjian, M J Keating, R S Walters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2015
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
Fabiola Cervantes-Gomez, Betty Lamothe, Jennifer A Woyach, et al.
Hematologic Pathology
|
January 1, 1987
Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia
E H Estey, M J Keating, D O Dixon, et al.
Annals of Internal Medicine
|
July 1, 1980
4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia
S S Legha, M J Keating, A R Zander, et al.
The EMBO Journal
|
September 16, 2005
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma
Geetha Achanta, Ryohei Sasaki, Li Feng, et al.
Acta Haematologica
|
January 1, 1987
Comparison of results of salvage therapy in adult acute myelogenous leukemia
M J Keating, E Estey, H M Kantarjian, et al.
European Journal of Haematology
|
January 10, 2008
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
Alessandra Ferrajoli, William G Wierda, Ruth LaPushin, et al.
Digestive Diseases (Basel, Switzerland)
|
January 1, 1993
Non-surgical approaches to stones in the biliary tree
J J Keating, O I Corrigan, A Chua, et al.
Cancer
|
November 15, 1993
Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission
H M Kantarjian, E Estey, S O'Brien, et al.
Cancer
|
March 1, 1989
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia
H M Kantarjian, M J Keating, R S Walters, et al.
Page
of 112
Search research articles
Search
Showing results (511-520 of 1,115) with videos related to
Sort By:
Page
of 112
Cancer
|
April 1, 1987
Role of maintenance chemotherapy in acute promyelocytic leukemia
H M Kantarjian, M J Keating, R S Walters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2015
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
Fabiola Cervantes-Gomez, Betty Lamothe, Jennifer A Woyach, et al.
Hematologic Pathology
|
January 1, 1987
Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia
E H Estey, M J Keating, D O Dixon, et al.
Annals of Internal Medicine
|
July 1, 1980
4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia
S S Legha, M J Keating, A R Zander, et al.
The EMBO Journal
|
September 16, 2005
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma
Geetha Achanta, Ryohei Sasaki, Li Feng, et al.
Acta Haematologica
|
January 1, 1987
Comparison of results of salvage therapy in adult acute myelogenous leukemia
M J Keating, E Estey, H M Kantarjian, et al.
European Journal of Haematology
|
January 10, 2008
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
Alessandra Ferrajoli, William G Wierda, Ruth LaPushin, et al.
Digestive Diseases (Basel, Switzerland)
|
January 1, 1993
Non-surgical approaches to stones in the biliary tree
J J Keating, O I Corrigan, A Chua, et al.
Cancer
|
November 15, 1993
Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission
H M Kantarjian, E Estey, S O'Brien, et al.
Cancer
|
March 1, 1989
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia
H M Kantarjian, M J Keating, R S Walters, et al.
Page
of 112